Instapath
About:
Instapath provides digital imaging tools for rapid on-site pathology evaluation to repeat biopsy procedures and increase hospital revenue.
Website: http://www.instapathbio.com
Twitter/X: instapathbio
Top Investors: National Science Foundation, Y Combinator, MassChallenge
Description:
Over 7 million Americans need biopsy procedures every year, costing over $8 billion; 20% of procedures fail to render an accurate diagnosis. Over 1 million patients have to go through costly, painful repeat biopsy procedures. Instapath makes digital microscopic imaging devices that improve rapid on-site evaluation (ROSE) of biopsies, reducing the need for repeat procedures and increasing operating room capacity and hospital revenue.
$3.16M
$1M to $10M
Houston, Texas, United States
2017-07-01
info(AT)instapathbio.com
Mei Wang
1-10
2021-03-09
Private
© 2025 bioDAO.ai